HYPMY (Hypera) Inventories, Finished Goods : $140 Mil (As of Sep. 2024)

View and export this data going back to . Start your Free Trial

What is Hypera Inventories, Finished Goods?

Hypera's quarterly finished goods declined from Mar. 2024 ($167 Mil) to Jun. 2024 ($141 Mil) and declined from Jun. 2024 ($141 Mil) to Sep. 2024 ($140 Mil).

Hypera's annual finished goods increased from Dec. 2021 ($69 Mil) to Dec. 2022 ($119 Mil) and increased from Dec. 2022 ($119 Mil) to Dec. 2023 ($181 Mil).

Hypera Inventories, Finished Goods Historical Data

The historical data trend for Hypera's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hypera Inventories, Finished Goods Chart

Hypera Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Inventories, Finished Goods

Get a 7-Day Free Trial

44.19

64.85

68.58

118.57

181.18

Hypera Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Inventories, Finished Goods	Get a 7-Day Free Trial															166.65	181.18	167.06	140.90	139.74

Hypera Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

Hypera Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hypera SA (OTCPK:HYPMY) » Definitions » Inventories, Finished Goods

Comparable Companies

Traded in Other Exchanges

HYPE3:Brazil

Address

Avenida Magalhaes de Castro, 4800, 240 Floor Continental Tower Building, Bairro Cidade Jardim, Sao Paulo, SP, BRA, CEP 05676-120

Website

https://www.hypermarcas.com.br

Hypera SA is a specialty and generic drug manufacturing company. The company has a focus on the pharmaceutical segments of the Brazilian market, along with a presence in nonprescription drugs and branded generics. Hypermarcas also possesses a share of generic medicines and prescription products. The company also has a wide sales and distribution structure. The Company's operating segments are Consumer Health, Branded Prescription, Similars e Generics, Skincare and Non-Retail Market.